Results 301 to 310 of about 261,543 (347)

Gonadotropin-releasing-hormone-receptor antagonists

The Lancet, 2001
Pulsatile gonadotropin-releasing hormone (GnRH) stimulates the pituitary secretion of both luteinising hormone (LH) and follicle-stimulating hormone (FSH) and thus controls the hormonal and reproductive function of the gonads. Blockade of GnRH effects may be wanted for a variety of reasons-eg, to prevent untimely luteinisation during assisted ...
J A, Huirne, C B, Lambalk
openaire   +2 more sources

GONADOTROPIN-RELEASING HORMONE AND ITS ANALOGS

Annual Review of Medicine, 1991
▪ Abstract  GnRH and its analogues have led to exciting new avenues of therapy in virtually every subspecialty of internal medicine as well as in gynecology, pediatrics, and urology. Since their discovery in 1971, it has been demonstrated that GnRH and its analogues enable medical professionals to influence the hypothalamic-pituitary-gonadal axis in ...
Jane F. Desforges, P. Michael Conn, William F. Crowley   +2 more
openaire   +3 more sources

Gonadotropin-Releasing Hormone

The New England journal of medicine, 1977
L J, Valenta, J C, Zolman
  +5 more sources

Model of gonadotropin-releasing hormone and gonadotropin-releasing hormone complex

Sexuality and Disability, 2006
Gonadotropin-releasing hormone (GnRH) neurons provide the primary driving force upon the other levels of the reproductive axis. Similar to other hormone, GnRH receptor can be identified. The main intracellular pathway activated by stimulation of GnRH receptors (GnRHRs) is related to Gq protein which induces a cytoplasmic metabolic cascade.
openaire   +1 more source

Immunobiology of gonadotropin-releasing hormone

Journal of Steroid Biochemistry, 1985
This article will review methods successful in inducing antibody responses against gonadotropin releasing hormone without the use of Freund's complete adjuvant (FCA), the characteristics of the antibodies produced, and will describe the dominant antigenic determinant(s) of the decapeptide and the use of monoclonal antibodies for suppression of estrus ...
openaire   +2 more sources

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Breast Cancer Statistics, 2022

Ca-A Cancer Journal for Clinicians, 2022
Hyuna Sung, Kimberly D Miller, Rebecca L Siegel   +2 more
exaly  

Control of puberty onset and fertility by gonadotropin-releasing hormone neurons

Nature Reviews Endocrinology, 2016
A. Herbison
semanticscholar   +1 more source

Gonadotropin-releasing hormone

Reactions Weekly, 2016
openaire   +2 more sources

Gonadotropin releasing hormone

Reactions Weekly, 2015
  +4 more sources